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Identity 
Inheritance: Genetic heterogeneity; majority of cases 
autosomal dominant, occasionally with variable 
expression (incomplete dominance) manifesting as 
mild anemia or only macrocytosis and/or elevated 
erythrocyte adenosine deaminase activity (eADA) in 
transmitting parent or in siblings; some cases 
apparently autosomal recessive, not linked to 19q. 
Clinics 
- Chronic constitutional aregenerative anemia with 
absent or decreased red cell precursors in bone marrow. 
- Macrocytosis elevated fetal hemoglobin and increased 
eADA. 
- Physical abnormalities in about 40% of DBA cases 
including craniofacial and thumb abnormalities, atrial 
or ventrucular septal defects, short stature, mild 
retardation, etc. 
- Hematologic malignancy: in 2.5% of all reported 
cases of DBA; primarily ANLL with no FAB 
preference but also ALL, Hodgkin's disease. 
- Solid tumors include carcinoma of liver, stomach, 
osteogenic sarcoma. 
- Age of malignancy onset from 2 to 43 years. 
- Disease-related and treatment-related factors, i.e.
allosensitization and iron overload, contribute to 
malignancy. 
Treatment 
Corticosteroids, transfusion, bone marrow transplant. 
Evolution 
Some patients enter remission, with or without 
corticosteroid therapy. 
Prognosis 
Median survival: 38 years. 




Description: Ribosomal protein S19; ribosomal 
proteins are a major component of cellular proteins. I  
general their function(s), aside from being part of the 
ribosome, are unknown. However, RPS19 protein was 
shown to be essential for 18S rRNA maturation and 
40S subunit synthesis. Haplo-insufficiency of the 
protein encoded by the mutated gene is a likely 
mechanism underlying the pathogenesis of DBA. 
Mutations 
Germinal: 62 different heterozygous mutations in 
RPS19 were identified and reported in 113 of the 457
(about 25%) DBA probands. They were non-sense, 
frameshift, splice site and missense mutations. Several 
patients had disease-associated chromosomal 
abnormalities in DBA region, including t(X;19), 




Description: ribosomal protein S24. 
Mutations 
Germinal: Three heterozygous mutations in RPS24 
(two nonsense and one splice site mutations causing 
premature termination codons and skipped exon, 
respectively) were identified among 185 RPS19-
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